Skip to main content
. 2022 Jan 29;62:16–21. doi: 10.1016/j.breast.2022.01.015

Table 2.

Characteristics of the screen-detected cancers by timeliness and risk factor grouping.

Characteristics None of the RFs∗
At least one RF∗
timely screens (<27mo)
Delayed screens (≥27mo)
timely screens (<27mo)
Delayed screens (≥27mo)
N % N % N % N %
Pathological tumour size category
pTis (DCIS) 364 23.2% 159 20.6% 551 22.5% 183 19.6%
pT1a (≤5 mm) 117 7.5% 44 5.7% 202 8.3% 54 5.8%
pT1b (>5 mm, ≤10 mm) 327 20.9% 161 20.9% 502 20.5% 152 16.2%
pT1c (>10 mm, ≤20 mm) 526 33.5% 275 35.7% 787 32.2% 306 32.7%
pT2 (>20 mm, ≤50 mm) 219 14.0% 117 15.2% 362 14.8% 210 22.4%
pT3 (>50 mm) 15 1.0% 14 1.8% 40 1.6% 31 3.3%
Unknown 8 . 1 . 8∗∗ . 7 .
Total 1568 770 2444 936
Axillary nodal status (invasive cancer)
Negative for metastasis 856 77.3% 408 73.9% 1342 79.3% 507 72.9%
Positive for metastasis 251 22.7% 144 26.1% 351 20.7% 188 27.1%
Unknown 105 . 60 . 208 . 64 .
Total 1107 552 1693 695

RF, risk factor; DCIS, ductal carcinoma in situ. ∗first-degree family history of breast cancer, HRT use, history of benign breast conditions, and self-reporting symptoms. Breast density was not included. ∗∗1 was also unclear whether it was DCIS or invasive.